Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) and Use of a Nasal Mupirocin Ointment in Oral Cancer Inpatients
- 30 November 2007
- journal article
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 65 (11), 2159-2163
- https://doi.org/10.1016/j.joms.2007.04.026
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The clinical significance of methicillin-resistant Staphylococcus aureusJournal of Hospital Infection, 2005
- Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care unitsCritical Care, 2005
- Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial InfectionsInfection, 2005
- Intranasal Mupirocin to Prevent PostoperativeStaphylococcus aureusInfectionsNew England Journal of Medicine, 2002
- Clinical Studies of Enteritis caused by Methicillin-resistant Staphylococcus aureusBritish Journal of Surgery, 2001
- Staphylococcal bacteraemia: the hospital or the home? A review of Staphylococcus aureus bacteraemia at Concord Hospital in 1993Australian and New Zealand Journal of Medicine, 1998
- Risk Factors for the Spread of Antibiotic-Resistant BacteriaDrugs, 1998
- Risk factors for methicillin-resistant staphylococcus aureus (MRSA) infection in a Japanese geriatric hospitalPublic Health, 1997
- [Relation between candidiasis and nutrition of patients and MRSA infection].Kansenshogaku Zasshi, 1997
- Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open wardJournal of Hospital Infection, 1996